Global Cosmetic Implants Market Outlook to 2028 – Rising Demand for Cosmetic Implants to Drive Growth –


DUBLIN–(BUSINESS WIRE)–The “Global Cosmetic Implants Market Outlook 2028: Analysis of Global Opportunities and Demand, Market Forecast to 2028” report has been added to from offer.

According to statistics, the global cosmetic implants market size was pegged at a value of USD 9,240.80 million in 2021 and is projected to reach USD 20,541.20 million by 2029, expanding with a CAGR of 9.75 % over the forecast period (2022 – 2029).

Cosmetic implants are devices or they can be implanted tissue inside or outside the human body. Implants deliver medicine, they help monitor our body’s activities such as organs, tissues and body systems. They are made of materials such as skin, bone, plastic and even ceramic.

The subsequent rise in the occurrence of birth defects like cleft lip and cleft palate is sure to skyrocket the use of cosmetic implants, which in turn will ensure the growth of the cosmetic implant market.

The increase in demand for cosmetic implants would lead to the growth in the use of implants.

The subsequent increase in birth defects would skyrocket the use of cosmetic implants, changing people’s lifestyles would increase the need for cosmetic products. According to the American Society of Plastic Surgeons, 17.7 million people underwent cosmetic surgery in 2018 and about 2.0% of this surgery took place in 2017. The increase in inactive lifestyle such as alcohol, smoking, diabetes, etc. may increase the risk of children being born with cleft lip and cleft palate. This increases the demand for cosmetic implants and in turn drives the growth of the implant market. According to the Centers for Disease Control and Prevention (CDC), approximately one in 16,000 babies in the United States will be born with a cleft lip or palate in 2020.

More so, the technological improvements in the cosmetic surgery industry in these implants would aid in the growth of the market. The increase in the number of cosmetic products approved by the (FDA), Food and Drug Administration is driving the expansion of the cosmetic implant market. Additionally, increasing R&D activities in surgical imaging technology is fueling the growth of the cosmetic implant market. Dentsply Sirona, the world leader in dental implants and prostheses, announced the introduction of the Axeos 3D/2D surgical imaging system in 2020. It improves clinical confidence for patients, creates a good patient experience and enables procedural extensions.

Additionally, the growing need for surgical implants to help improve the beauty and appearance of the face is propelling the cosmetic implant market. For example, Golderma, the world’s largest independent dermatology company, has obtained FDA clearance for Restylane Kysse, a hyaluronic acid (HA) filler that helps improve lip fullness. Also, it is used to repair wrinkles around the upper lip in people 21 years and older.

According to the International Society for Aesthetic Plastic Surgery (ISAPS), an estimated 10,129,528 cosmetic surgeries would be performed globally in 2020. Moreover, developments like these in the cosmetic implant industry would increase the market for cosmetics. In January 2021, Mentor Worldwide LLC, a subsidiary of Johnson and Johnson, a global leader in the manufacture of breast aesthetics, received FDA approval for its new product, MENTOR MemoryGel BOOST breast implant for augmentation. breast cancer in women aged 22 and over.

Impact of COVID-19

The SARS-CoV2 virus which emerged as an unknown pneumonia-like disease in December 2019, achieved global pandemic status, in March 2022. Like all other industries, the life science sector is also being hit hard by the COVID-19 pandemic. This is mainly due to a drop in the number of health care providers and a reduction in interactions with patients, as hospitals have redirected their resources to COVID-19.

As hospitals turned their attention to developing a cure for the pandemic, many patients around the world began avoiding visits to healthcare facilities and postponing preventive care, which in turn curbed the demand for non-COVID-19 products and trials. For example, since April 2020, almost 70% of clinical trials have been affected due to the suspension of recruitment and almost 13% have experienced delayed trials. However, a rapid shift in strategy by major market players given the existence of pandemic conditions will boost the market growth over the forecast period.

The dental impact segment is expected to grow at the fastest CAGR during the forecast period (2022-2029).

This is due to the increased use of many therapeutic dental implants in therapeutic areas. The increased availability and excellent results of technologically enhanced dental surgery are increasing the demand for this service.

Asia-Pacific regions hold the largest share of the global cosmetic implant market during the forecast period

According to the Ministry of Health and Welfare, dental caries affects 60% of the Indian population while 85% are affected by periodontal diseases. This presents opportunities for interested parties to take extensive action on a population affected by tooth loss.

In China and Japan, there is likely to be an increase in the use of therapeutics over a forecast period of 2022-2029. This is due to the growth of the senior-oriented market due to the increase in the population base.

Competitive analysis

Some of these key parts contributing to market growth include:

  • 3M company

  • AbbVie Inc.

  • Zimmer Holdings Inc.

  • Johnsons and Johnsons

  • Nascome

  • Dentsply Sirona Inc.

  • GC Aesthetic PLC.

For more information on this report, visit


Comments are closed.